The effect of concomitant COVID-19 infection on outcomes in patients hospitalized with heart failure

Nikhil Chatrath1, Nandita Kaza1, Punam A Pabari1

  • 1Department of Cardiology, Imperial College Healthcare NHS Trust, London, UK.

ESC Heart Failure
|October 11, 2020
PubMed

Insights

Patients with heart failure (HF) hospitalized with COVID-19 infection face a significantly higher risk of in-hospital death. This highlights the critical need to protect HF patients from COVID-19 exposure.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Patients with cardiovascular disease, particularly heart failure (HF), are recognized as a vulnerable population during the COVID-19 pandemic.
  • The specific impact of COVID-19 infection on mortality and complications in hospitalized HF patients remained largely unknown prior to this study.

Purpose of the Study:

  • To quantify the effect of COVID-19 infection on in-hospital mortality among patients with a pre-existing diagnosis of heart failure.
  • To assess the association between COVID-19 infection and adverse outcomes such as acute kidney injury and myocardial injury in HF patients.

Main Methods:

  • A retrospective analysis was conducted on 134 patients hospitalized with a diagnosis of heart failure between March 1 and May 6, 2020.
  • The study compared outcomes, including in-hospital mortality, acute kidney injury, and myocardial injury, between HF patients with and without concomitant COVID-19 infection.

Main Results:

  • Of 134 hospitalized HF patients, 40 (29.9%) had COVID-19. These patients experienced significantly higher in-hospital mortality (50.0% vs. 10.6%).
  • COVID-19 positive HF patients were more likely to develop acute kidney injury (45% vs. 24.5%), myocardial injury (57.5% vs. 31.9%), and require treatment for superadded bacterial infections (55% vs. 32.5%).

Conclusions:

  • Hospitalized patients with heart failure who contract COVID-19 have a very poor prognosis.
  • This study underscores the necessity of identifying heart failure patients as a high-risk group requiring specific shielding strategies to mitigate COVID-19 risks.
Abstract

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
332
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
502
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
547
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
122
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
294
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.4K